Physician profile
Adel E Chouchani
NPI 1255325650
$1,952.30
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,334 · 2020: $440 · 2021: $119 · 2022: $59.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $352.36 | 2019-2021 | |
| Pfizer INC. | $330.14 | 2019-2021 | |
| Abbvie INC. | $290.99 | 2019-2020 | |
| Duchesnay USA Incorporated | $158.32 | 2019 | |
| Radius Health, INC. | $123.92 | 2020-2021 | |
| Daiichi Sankyo INC. | $99.82 | 2019-2020 | |
| Therapeuticsmd, INC. | $96.71 | 2019-2020 | |
| Coopersurgical, INC. | $52.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.91 | 2019 | |
| Vertical Pharmaceuticals, LLC | $38.17 | 2019 | |
| Astellas Pharma US INC | $37.16 | 2019-2020 | |
| Minerva Surgical, INC | $33.55 | 2019 | |
| Avion Pharmaceuticals | $31.25 | 2019-2020 | |
| Lupin INC. | $31.03 | 2019 | |
| Mckesson Patient Care Solutions INC. | $29.77 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $26.15 | 2019-2020 | |
| Gilead Sciences, INC. | $25.05 | 2022 | |
| Medtronic, INC. | $20.62 | 2021 | |
| Davol INC. | $20.11 | 2020 | |
| Organon LLC | $19.74 | 2021 | |
| Hologic Sales and Service, LLC | $19.02 | 2019 | |
| Ethicon US, LLC | $18.16 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.64 | 2020 | |
| Exeltis, USA INC. | $16.08 | 2020 | |
| Olympus America INC. | $11.82 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adel Chouchani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.